Artiva Biotherapeutics to Present AlloNK Data at ACR Convergence

Artiva Biotherapeutics announced that it will present data on its AlloNK platform at the American College of Rheumatology (ACR) Convergence 2026. The presentations will include one oral and two poster sessions.